FDA advisers support approval of RSV vaccine to protect infants
Briefly

The first vaccine to protect infants from respiratory syncytial virus, or RSV, moved a step toward approval by the Food and Drug Administration with positive votes Thursday from a panel of experts.Kateryna Kon/Getty Images/Science Photo Library Advisers to the Food and Drug Administration recommended that the agency should approve the first vaccine to protect infants from RSV, or respiratory syncytial virus.
Read at www.npr.org
[
add
]
[
|
|
]